ProQR Therapeutics NV (PRQR)
NASDAQ
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current PRQR market cap is 155.39M. The company's latest EPS is EUR -0.3456 and P/E is -5.76.
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 697k | 1.24M | 3.28M | 4.66M | 6.46M |
| Operating Income | -9.39M | -8.81M | -9.2M | -8.08M | -3.6M |
| Net Income | -8.93M | -7.99M | -5.48M | -7.66M | -2.69M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Revenue | 1.93M | 9.45M | 2.4M | 4.8M | 6.59M |
| Operating Income | -57.02M | -42.69M | -56.89M | -64.72M | -34.7M |
| Net Income | -56.48M | -46.57M | -61.62M | -65.11M | -28.12M |
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 158.01M | 147.99M | 137.88M | 123.88M | 118.05M |
| Total Liabilities | 99.31M | 96.49M | 96.49M | 89.06M | 85.2M |
| Total Equity | 58.7M | 51.5M | 41.39M | 34.82M | 32.85M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Total Assets | 117.54M | 98.73M | 209.58M | 171.32M | 137.88M |
| Total Liabilities | 23.7M | 42.18M | 96.35M | 106.21M | 96.49M |
| Total Equity | 93.83M | 56.55M | 113.23M | 65.11M | 41.39M |
| Quarter End | Mar 2023 | Jun 2023 | Dec 2023 | Mar 2024 | Jun 2024 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | 44.73M | -10.35M | 21.55M | -15.13M | -21.39M |
| Investing | -89k | -294k | 4.28M | -17.73M | -18M |
| Financing | -259k | -643k | -2.28M | -419k | -701k |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| EUR (€) | EUR (€) | EUR (€) | EUR (€) | EUR (€) | |
| Operating | -43.97M | -47.06M | -26.01M | -68.51M | 21.55M |
| Investing | -580k | -924k | -425k | -702k | 4.28M |
| Financing | 50.2M | 14.5M | 136.83M | -30.89M | -2.28M |
| Market Cap | 155.39M |
| Price to Earnings Ratio | -5.76 |
| Price to Sales Ratio | 24.54 |
| Price to Cash Ratio | 1.36 |
| Price to Book Ratio | 3.91 |
| Dividend Yield | - |
| Shares Outstanding | 81.35M |
| Average Volume (1 week) | 101.48k |
| Average Volume (1 Month) | 77.25k |
| 52 Week Change | 29.93% |
| 52 Week High | 3.29 |
| 52 Week Low | 1.11 |
| Spread (Intraday) | 0.02 (1.05%) |
| Company Name | ProQR Therapeutics NV |
| Address |
zernikedreef 9 leiden, south holland 2333 CK |
| Website | https://www.proqr.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
